(Video) VCS Interview with Dr. Andrew Novosad

Dr. Sue Cancer Vet posted an oncologist interview with Dr. Andrew Novosad as part of her VCS interview series. Novosad described TANOVEA-CA1 (rabacfosadine for injection) as the most significant highlight of this year’s VCS Conference and shared why he is so excited about implementing this novel treatment further in his practice.

For more information on TANOVEA-CA1 please go to tanovea.com.

0 Comments

Please provide us with the following before posting a comment